Pharmaceutical Technology's In the Lab eNewsletter
Clear Advantage is a product line of multichannel reagent reservoirs to be used for creating a next-gen sequencing library
Integra Biosciences now offers Clear Advantage, a product line of multichannel reagent reservoirs that, along with its Voyager product line of adjustable-tip spacing electronic multichannel pipettes, helps ensure efficient and reliable pipetting for the preparation of next-generation sequencing (NGS) libraries. The products help reduce experimental costs, according to the company.
The Clear Advantage reagent reservoir portfolio saves money and space by using disposable inserts that fit into reusable bases. The reservoirs are offered in 10-mL, 25-mL, and 100-mL sizes, now available with the SureFlo system, which minimizes dead volumes. The SureFlo system works through a series of tiny channels that enable pipette tips to sit on the bottom of a reservoir without sealing or creating a vacuum. This ensures the smooth flow of reagents by preventing liquid from “popping” into tips, filters, or pipettes-an issue that can lead to cross-contamination, inaccurate results, and increased pipette maintenance. Each reservoir also has a specially formulated inert, hydrophilic treatment that prevents liquid from pooling. Thus, the reservoir offers the lowest dead volumes on the market, with all reservoirs offering dead volumes of less than 50 μl.
SureFlo is made up of polystyrene and polypropylene reservoirs, appropriate for use with expensive reagents, such as polymerase chain reaction master mixes.
Source: Integra Biosciences
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.